InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Imran Mir A, Director. Director active across 1 company, notably Rani Therapeutics Holdings, Inc.. In total, 6 filings have been published. Breakdown: 2 buys · 1 sell. Total volume traded: €1.8m. History available since 3 February 2022. The latest transaction was disclosed on 21 July 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Imran Mir A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
36,000 shares@ US$0.69Class A Common StockSEC:0001031686-26-000006:0
Canonical exit: 19 Oct 2026 (T+90)
2,083,334 shares@ US$0.60559.7% of flowClass A Common StockSEC:0001031686-25-000004:0
Canonical exit: 21 Jan 2026 (T+90)
7,694 shares0Class B Common StockSEC:0001209191-22-047661:0
71,042 shares@ US$10.51100.0% of flowClass A Common StockSEC:0001209191-22-046958:0
2,309,490 shares0Class B Common StockSEC:0001179110-22-002126:0
827,467 shares0Class A Common StockSEC:0001209191-22-007642:0
6 of 6 declarations
About Imran Mir A
Imran Mir A is a Board Member at Rani Therapeutics Holdings, Inc. In this role, he participates in overseeing the company's activities and making strategic decisions. With experience in the biopharmaceutical sector, he contributes to guiding the company's research and development initiatives.
